Effects of Succinylcholine on Nonintubated Thoracoscopic Surgery

NCT03469323 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-03-20

No results posted yet for this study

Summary

A safe and effective surgical environment is important for nonintubated thoracoscopic surgery. The investigators hypothesize that mini-dose succinylcholine can induce ultra-short period of apnea, by which the ventilatory responses to open pneumothorax were abolished and may facilitate rapid and satisfying collapse of the operated lung during nonintubated thoracoscopic surgery.

Conditions

  • Tumor of Lung Parenchyma
  • Complication of Ventilation Therapy
  • Atelectasis

Interventions

DRUG

Succinylcholine

Giving mini-dose succinylcholine to facilitate lung collapse during nonintubated VATS.

DRUG

Placebo

Giving placebo (normal saline) to facilitate lung collapse during nonintubated VATS.

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Ming-Hui Hung, MD, MSc · National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-31
Primary Completion
2019-07-31
Completion
2019-07-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03469323 on ClinicalTrials.gov